¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : º¤½ºÄÚ Á¦2Àü½ÃÀå 1Ãþ 121È£

±³À°ÁÖÁ¦ : 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­ÁÂ

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ¿ï°æÁöȸ

´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 051-000-0000

À̸ÞÀÏ : sericonf@gmail.com

±³À°Á¾·ù : ³»°ú, ÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇ·áÁ¤Ã¥, ±âŸ

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:00~09:15 Optimal antiplatelet strategy in patients both at high ischemic and bleeding risks ¾È¼­Èñ(¿ï»ê´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:15~09:30 Optimal revascularization strategy for ICMP ±è¼öÈ«(ºÎ»ê º¸Èƺ´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:30~09:45 Early versus delayed intervention for NSTEMI patients ±èÇÑ°á(°æ»ó±¹¸³´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:45~10:00 Physiology guided vs imaging guided PCI ¿ÀÁØÇõ(ºÎ»ê´ëº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:00~10:20 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:20~10:30 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:30~10:45 Practical tips for diagnosing HFpEF, featuring concept of congestion ÀåÁ¤À±(â¿ø°æ»ó´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:45~11:00 How to implement 4 pillar therapy in HFrEF À̼ö¿ë(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:00~11:15 How to detect & treat ATTR amyloidosis in daily practice ¼­Á¤¼÷(ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:15~11:30 Approach to asymptomatic coronary artery calcium in chest CT ±èºÀÁØ(°í½Å´ëº¹À½º´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:30~11:50 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:50~12:00 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 12:00~12:30 Earlier & Lower is Better! - Clinical Benefits of Evolocumab in ACS Á¶¿ë¶ô(µ¿¾Æ´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 12:30~13:00 Familial Hypercholesterolemia: It¡¯s Possible! How to Screen and Treat? ¹Ú°æ¹Î(¿ï»ê´ëº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:00~13:15 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:15~13:30 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:30~13:45 SGLT2 inhibitor and AF Ȳ±â¿ø(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:45~14:00 The use of non‐vitamin K oral anticoagulants in patients with AF and dialysis °ûÇýºó(â¿ø»ï¼ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:00~14:15 Left Bundle Branch Pacing Versus Biventricular Pacing In heart failure ¹Ú¿µ¾Æ(ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:15~14:30 New Technology in AF Ablation: Pulsed Field Ablation ÀÓ¼ºÀÏ(°í½Å´ëº¹À½º´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:30~14:50 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:50~15:00 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 15:00~15:45 Patient indication & assessment of TEER during procedure ¹Ú¼ºÁö(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 15:45~16:30 A to Z of TEER procedures ÇÑÁÖ¿ë(»ï¼º¼­¿ïº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 16:30~16:50 Discussion ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (3ÀÏÂ÷) : 2023-04-29
´ÙÀ½±Û ¿µ³²»ý½Ä³»ºÐºñÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2023-04-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
255 ¼­¿ï »ï¼º¼­¿ïº´¿ø ¾ÓÄÚ¸£¼­¿ï 2018 : 2018-09-14 0 528 2018-07-28
254 ¼­¿ï ¼­¿ïƯº°½ÃÀÇ»çȸ °­ÀÇ(Àú½ÅÀåÄ¡·á, ¹æ»ç¼±Ä¡·á) : 2018-09-13 0 1,148 2018-07-28
253 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) Á¡¸·Áúȯ 2) ÇǺΠ¸é¿ªÇÐ : 2018-09-13 0 818 2018-07-28
252 ¼­¿ï »ï¼º¼­¿ïº´¿ø ¾ÓÄÚ¸£¼­¿ï 2018 : 2018-09-13 0 410 2018-07-28
251 ºÎ»ê ´ëÇÑ°£ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2018-09-13 0 579 2018-07-28
250 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø ÀӽŠ¹× ¼öÀ¯±â°£ Áß ¾à¹° Ä¡·á : 2018-09-12 0 633 2018-07-28
249 Ãæ³² ´ëÇÑ°¡Á¤ÀÇÇÐȸ °»³â±â È£¸£¸ó Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-09-12 0 531 2018-07-28
248 ¼­¿ï »ï¼º¼­¿ïº´¿ø ¾ÓÄÚ¸£¼­¿ï 2018 : 2018-09-12 0 673 2018-07-28
247 ÀÎõ ÀÎÇÏ´ëÇб³º´¿ø ³ì³»ÀåȯÀÚÀÇ ¾à¹°Ä¡·á : 2018-09-11 0 346 2018-07-28
246 ÃæºÏ 2018³â ÃæºÏ´ëÇб³º´¿ø ºñ´¢ÀÇÇаú ¿¬¼ö°­Á : 2018-09-11 0 650 2018-07-28
245 ¼­¿ï ´ëÇѾȰúÇÐȸ ¼­¿ï ³²ºÎ Áöȸ ¿¬¼ö ±³À° : 2018-09-10 0 681 2018-07-28
244 ¼­¿ï Á¦ 1ȸ °­ºÏ»ï¼ºº´¿ø ¼Ò¾Æû¼Ò³â°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-09 0 750 2018-07-28
243 ¼­¿ï 2018³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ ¼Ò¾Æû¼Ò³â ¿µ¾ç ½ÉÆ÷Áö¾ö : 2018-09-09 0 747 2018-07-28
242 ¼­¿ï 2018³âµµ ´ëÇÑ°¡Á¤ÀÇÇаúÀÇ»çȸ Ãß°èÇмú´ëȸ ¹× Á¦40ȸ ¿¬¼ö°­Á : 2018-09-09 1 1,330 2018-07-28
241 ´ë±¸ ´ëÇÑ°ñÀýÇÐȸ Á¦1ȸ »óÁö°ñÀý ½ÉÆ÷Áö¾ö : 2018-09-09 0 658 2018-07-28
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷